A significant shift in this disease care is developing with the introduction of rapidly dispersing GLP-1 medications. These cutting-edge formulations bypass the Wegovy manufacturer traditional injection method , offering a simple oral alternative for individuals managing this disease . The ability to quickly disperse in the mouth allows for faster